VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MET
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
METMetLife, Inc.
$91.67$59.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMETQuarterly Financials

MetLife, Inc. (MET) Quarterly Financials

120+ quarters historyFree accessUpdated daily

MetLife, Inc. (MET) quarterly income statement — complete revenue, gross profit & net income history

MET Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue19.07B23.81B16.88B17.18B18.26B18.44B18.3B17.49B15.9B19.03B15.87B16.62B15.39B16.32B22.28B15.47B15.4B20.09B16.91B19.59B
Revenue Growth %4.44%29.14%-7.74%-1.8%14.85%-3.09%15.33%5.22%3.34%16.62%-28.8%7.43%-0.11%-18.78%31.81%-21%-1.01%3.46%5.56%38.92%
Medical Costs & Claims11.97B16.54B13.94B12.64B13.54B13.58B12.85B13.1B11.41B15.85B13.21B14.1B13.08B12.51B18.86B12.5B11.46B16.56B12.89B12.1B
Medical Cost Ratio %62.76%69.47%82.6%73.57%74.15%73.62%70.23%74.91%71.75%83.32%83.25%84.82%84.98%76.69%84.66%80.77%74.42%82.44%76.24%61.77%
Gross Profit7.1B7.27B2.94B4.54B4.72B4.86B5.45B4.39B4.49B3.17B2.66B2.52B2.31B3.8B3.42B2.98B3.94B3.53B4.02B7.49B
Gross Margin %37.24%30.53%17.4%26.43%25.85%26.38%29.77%25.09%28.25%16.68%16.75%15.18%15.02%23.31%15.34%19.23%25.58%17.56%23.76%38.23%
Gross Profit Growth %50.46%49.47%-46.08%3.46%5.1%53.25%104.93%73.92%94.37%-16.56%-22.26%-15.19%-41.35%7.82%-14.89%-60.26%67.52%43.36%36.82%228.95%
Operating Expenses5.6B6.15B1.73B3.56B3.37B3.48B3.45B3.19B3.45B2.23B2.12B2.09B2.05B2.08B2B1.99B2B2.22B1.98B3B
OpEx / Revenue %29.34%25.84%10.23%20.73%18.44%18.89%18.87%18.22%21.68%11.74%13.39%12.59%13.35%12.73%8.99%12.85%13.02%11.06%11.68%15.32%
Depreciation & Amortization00000000000000000000
Combined Ratio %92.1%95.31%92.83%94.29%92.59%92.51%89.1%93.13%93.43%95.05%96.63%97.41%98.33%89.42%93.65%93.62%87.44%93.5%87.92%77.09%
Operating Income1.51B1.12B1.21B980M1.35B1.38B1.99B1.2B1.04B941M534M430M257M1.73B1.42B987M1.94B1.31B2.04B4.49B
Operating Margin %7.9%4.69%7.17%5.71%7.41%7.49%10.9%6.87%6.57%4.95%3.37%2.59%1.67%10.58%6.35%6.38%12.56%6.5%12.08%22.91%
Operating Income Growth %11.3%-19.12%-39.32%-18.47%29.57%46.76%273.41%179.53%306.61%-45.51%-62.26%-56.43%-86.72%32.24%-30.71%-78%564.95%696.34%121.24%2177.66%
EBITDA1.77B1.38B1.48B1.25B1.61B1.64B2.25B1.46B1.31B1.21B799M686M512M1.98B1.65B1.21B2.16B1.53B2.28B4.71B
EBITDA Margin %9.29%5.79%8.77%7.27%8.83%8.89%12.3%8.34%8.23%6.36%5.04%4.13%3.33%12.1%7.42%7.85%14.02%7.62%13.5%24.07%
Interest Expense265M263M271M269M258M259M257M257M264M269M265M256M255M248M239M226M225M224M240M228M
Non-Operating Income-265M-263M-271M-269M-258M-259M-257M-257M-264M-269M-265M-256M-255M-248M-239M-227M-225M-224M-240M-228M
Pretax Income1.51B1.12B1.21B980M1.35B1.38B1.99B1.2B1.04B941M534M430M257M1.73B1.42B988M1.94B1.31B2.04B4.49B
Pretax Margin %7.9%4.69%7.17%5.71%7.41%7.49%10.9%6.87%6.57%4.95%3.37%2.59%1.67%10.58%6.35%6.39%12.56%6.5%12.08%22.91%
Income Tax345M301M308M245M404M106M653M249M170M327M39M22M172M381M248M73M296M95M453M1.07B
Effective Tax Rate %22.89%26.95%25.45%25%29.84%7.68%32.75%20.72%16.27%34.75%7.3%5.12%66.93%22.06%17.53%7.39%15.3%7.27%22.18%23.96%
Net Income1.19B809M896M729M945M1.27B1.34B946M867M607M489M402M80M1.34B1.16B910M1.63B1.21B1.58B3.41B
Net Margin %6.21%3.4%5.31%4.24%5.17%6.89%7.33%5.41%5.45%3.19%3.08%2.42%0.52%8.23%5.21%5.88%10.61%6%9.37%17.4%
Net Income Growth %25.4%-36.35%-33.23%-22.94%9%109.39%174.44%135.32%983.75%-54.8%-57.92%-55.82%-95.1%11.45%-26.64%-73.29%356.42%662.66%124.36%2249.66%
EPS (Diluted)1.741.171.221.031.281.781.811.281.100.770.560.480.021.661.371.081.891.391.773.83
EPS Growth %35.94%-34.27%-32.6%-19.53%16.36%131.17%223.21%166.67%6045.25%-53.61%-59.12%-55.56%-99.05%19.42%-22.6%-71.8%472.73%892.86%156.52%5040.94%
EPS (Basic)1.751.171.231.041.291.791.821.281.110.770.560.480.021.691.381.091.911.401.783.85
Diluted Shares Outstanding655.7M664.96M669.1M675M687M697.9M703.7M714.7M728.4M745.46M755.5M769.6M781.2M790.2M800.7M814.5M830.5M845.2M861.2M879.7M